1Gheorghiade M, Zannad F, Sopko G, et al. The International Working Group on Acute Heart Failure Syndrome. Acute heart failure syndrome:current state and framework for future research [ J ]. Circulation ,2005,112(25) : 3958 -3968.
3Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagoosis of heart failure [J]. N Engl J Med,2002,347(3): 161 -167.
4Publication Committee for the VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure : a randomized controlled trial [ J ]. JAMA, 2002,287 : 1531 - 1540.
5Lewis DA, Gurram NR, Abraham WT, et al. Effect of nesiritide versus milrinone in the treatment of acute decompensated heart failure[ J ]. Am J Health Syst Pharm,2003,60(Suppl4) : S16 - S20.
6Elkayam U, Akhter MW, Singh H, et al. Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitreglycerin in patients with decompensated heart failure [ J ]. Am J Cardiol,2004,93: 237 - 240.
7Sackner-Bemstein JD, Kowalski M, Fox M. Short-term risk of death after treatment with nesiritide for decompensated heart failure. A pooled analysis of randomized controlled trials [ J ]. JAMA, 2005, 293:1900 - 1905.
8Clyde W Yancy, Henry Krum, Barry M Massie, et al. The second follow-up serial infusions of nesiritide ( FUSION Ⅱ ) trail for advanced heart failure :study rational and design[J]. Am Heart J,2007,153 (47):82 -85.
9Hauptman PJ, Schnitzler MA, Swindle J, et al. Use of nesiritide before and after publications suggesting drug-related risks in patients with acute decompensated heart failure [ J ]. J Am Med Assoc, 2006,296 ( 15 ) : 1877 - 1884.
